Pui, Ching-Hon <br/><br/>
Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Nov 2005 
 - 7936-41 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2004.01.0033  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Child<br/>Child, Preschool<br/>Combined Modality Therapy<br/>Cranial Irradiation<br/>Etoposide--administration & dosage<br/>Female<br/>Humans<br/>Infant<br/>Male<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--mortality<br/>Prognosis<br/>Remission Induction<br/>Risk Factors<br/>Survival Rate<br/>Teniposide--administration & dosage